Meloxicam
Brand names: Mobic
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Key Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Meloxicam is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.
Emergency Information
Poison Control: 1-800-222-1222
How does Meloxicam work?
Meloxicam belongs to the NSAID class of medications, specifically the enolic acid (oxicam) subclass. NSAIDs work by inhibiting cyclooxygenase (COX) enzymes, which are essential for producing prostaglandins — hormone-like chemicals that play key roles in inflammation, pain, and other bodily functions [1, 2, 13].
There are two main COX enzymes: COX-1 and COX-2. COX-1 is present in most tissues and produces prostaglandins that protect the stomach lining, support kidney function, and help regulate blood clotting. COX-2 is primarily induced at sites of inflammation and produces prostaglandins that cause pain, swelling, redness, and heat [1, 13].
Meloxicam preferentially inhibits COX-2 over COX-1, meaning it primarily targets the inflammatory prostaglandins while relatively sparing the protective ones. This preferential selectivity (though not absolute like the now-withdrawn rofecoxib/Vioxx) explains why meloxicam tends to cause fewer gastrointestinal side effects than non-selective NSAIDs like ibuprofen or naproxen [1, 7, 9, 10].
By blocking COX-2, meloxicam reduces the production of inflammatory prostaglandins at the site of joint inflammation. This leads to decreased pain, reduced swelling, less stiffness, and improved joint function [1]. The effect is symptomatic — meloxicam relieves symptoms but does not modify the underlying disease process in osteoarthritis or rheumatoid arthritis.
Meloxicam is absorbed well after oral administration and has a long half-life of approximately 20 hours, allowing once-daily dosing [1, 9]. Steady-state levels are reached within 3-5 days of regular dosing. Peak plasma concentration occurs at 4-5 hours after an oral dose [1, 9].
What to expect when starting Meloxicam
When you start meloxicam for arthritis, you may notice pain relief within the first few days, but the full anti-inflammatory effect develops over 1-2 weeks of consistent daily use [1, 9]. Unlike quick-acting pain relievers like ibuprofen, meloxicam's longer half-life means it works best when taken regularly rather than as-needed.
Take meloxicam once daily, preferably at the same time each day. It can be taken with or without food, but taking it with food may reduce the chance of stomach upset [1, 2].
Common side effects include stomach discomfort, diarrhea, flu-like symptoms, and headache. These are usually mild [1]. However, all NSAIDs carry risks of serious gastrointestinal and cardiovascular events (see boxed warnings), so use the lowest effective dose for the shortest duration possible [1, 3, 4, 5].
If you experience any of the following, contact your doctor immediately: black or tarry stools, vomiting blood, persistent stomach pain, chest pain, shortness of breath, weakness on one side of the body, or sudden severe headache. These could indicate serious GI bleeding [14] or cardiovascular events [3, 5].
Patients at higher risk for GI complications (history of ulcers, age >65, concomitant aspirin/corticosteroid use, anticoagulant use) may benefit from co-prescription of a proton pump inhibitor for gastroprotection [1, 14].
If you have been taking meloxicam regularly and wish to stop, you can generally discontinue without tapering, as NSAIDs do not cause physical dependence or withdrawal [1].
What are the common side effects of Meloxicam?
Common
- Diarrhea4-8%
- Upper abdominal pain/dyspepsia4-5%
- Nausea4-7%
- Flu-like symptoms5-7%
- Headache3-8%
- Edema (fluid retention/swelling)2-5%
- Dizziness2-4%
- Flatulence3-4%
- Upper respiratory infection5-8%
- Rash/pruritus1-3%
What are the serious side effects of Meloxicam?
Serious
- Gastrointestinal bleeding, ulceration, or perforation1-4% per year with chronic NSAID use; higher in elderly, prior ulcer history, concurrent anticoagulants
- Cardiovascular thrombotic events (heart attack, stroke)Increased risk with prolonged use; risk begins early in treatment
- Acute kidney injury / renal papillary necrosisUncommon; higher risk in elderly, volume-depleted, or those with pre-existing renal disease
- Hepatotoxicity (elevated liver enzymes, liver failure)Elevated ALT/AST in 1-5%; serious hepatotoxicity is very rare
- Serious skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)Very rare
- Heart failure exacerbationNSAIDs increase risk of heart failure hospitalization
- Severe allergic/anaphylactoid reactionsVery rare; higher risk in patients with aspirin-sensitive asthma (Samter triad)
What drugs interact with Meloxicam?
- MajorAspirin (low-dose) — Concomitant use of meloxicam with low-dose aspirin increases the risk of GI bleeding without proportionally increasing cardiovascular benefit. Meloxicam may also interfere with aspirin's antiplatelet effect by competing for the COX-1 binding site. If both are necessary, take aspirin at least 2 hours before meloxicam.
- MajorAnticoagulants (warfarin, rivaroxaban, apixaban) — NSAIDs impair platelet function and increase GI bleeding risk. Combining with anticoagulants significantly increases the risk of bleeding. Monitor closely for signs of bleeding. Consider gastroprotection with a PPI if the combination is necessary.
- ModerateACE inhibitors and ARBs (lisinopril, losartan) — NSAIDs can reduce the antihypertensive effect of ACE inhibitors and ARBs. The combination also increases the risk of acute kidney injury, especially with concurrent diuretic use (triple whammy). Monitor blood pressure and renal function.
- ModerateDiuretics (HCTZ, furosemide) — NSAIDs can reduce the diuretic and antihypertensive effects of diuretics. The combination increases the risk of acute kidney injury. Maintain adequate hydration and monitor renal function.
- ModerateLithium — NSAIDs can increase lithium levels by reducing renal lithium clearance. Meloxicam increased lithium Cmax by 16% in one study. Monitor lithium levels when starting or stopping meloxicam.
- ModerateMethotrexate — NSAIDs can reduce the renal clearance of methotrexate, increasing its toxicity. Use caution with moderate-to-high dose methotrexate. Monitor blood counts and renal function.
- ModerateSSRIs/SNRIs — Both NSAIDs and serotonergic antidepressants impair platelet function. The combination increases the risk of GI bleeding (2-3 fold increase). Consider gastroprotection with a PPI if both are necessary.
- MajorOther NSAIDs (ibuprofen, naproxen) — Do not combine meloxicam with other NSAIDs. The combination increases the risk of GI bleeding, ulceration, and renal injury without providing proportional additional pain relief. This includes OTC NSAIDs.
Can I eat certain foods or drink alcohol with Meloxicam?
Meloxicam can be taken with or without food. Taking it with food or milk may reduce gastrointestinal side effects (stomach upset, nausea) [1, 2].
Alcohol should be limited or avoided. Both meloxicam and alcohol irritate the stomach lining and increase the risk of GI bleeding [1, 14]. The combination also increases the risk of kidney injury. Limit alcohol to occasional, moderate intake.
Stay adequately hydrated. NSAIDs can affect kidney function, and dehydration increases this risk [1]. Drink adequate fluids, especially in hot weather or during exercise.
There are no significant food interactions that affect meloxicam absorption or metabolism [1, 9].
Drug interactions of note [1, 14]: Avoid combining meloxicam with other NSAIDs (including OTC ibuprofen, naproxen, or high-dose aspirin for pain). Meloxicam may reduce the antihypertensive effect of ACE inhibitors, ARBs, and diuretics. The combination of an NSAID + ACE inhibitor/ARB + diuretic ("triple whammy") significantly increases the risk of acute kidney injury [1, 14].
What is the typical dosage for Meloxicam?
Osteoarthritis [1]: - Starting and usual dose: 7.5 mg once daily - Maximum dose: 15 mg once daily - Use the lowest effective dose for the shortest duration
Rheumatoid arthritis [1]: - Starting and usual dose: 7.5 mg once daily - Maximum dose: 15 mg once daily
Juvenile rheumatoid arthritis (children 2+ years) [1]: - 0.125 mg/kg once daily - Maximum: 7.5 mg once daily - Oral suspension (7.5 mg/5 mL) available for children
Available forms [1]: - Tablets: 7.5 mg, 15 mg - Oral suspension: 7.5 mg/5 mL - Oral disintegrating tablets: 7.5 mg, 15 mg
Renal impairment [1]: No dose adjustment for mild-moderate; not recommended in severe renal impairment or patients on dialysis (NSAID-induced renal effects) Hepatic impairment [1]: No dose adjustment for mild-moderate; use with caution in severe hepatic impairment
Critical [1, 3, 5]: Use the lowest effective dose for the shortest duration consistent with treatment goals. Do not exceed 15 mg/day. Periodic reassessment of the need for continued NSAID therapy is recommended. The FDA boxed warning highlights both cardiovascular thrombotic risks and serious GI bleeding risks for all NSAIDs [5, 6].
How much does Meloxicam cost?
Generic meloxicam is widely available and extremely affordable [1, 11]. A 30-day supply of generic meloxicam 15 mg typically costs $3-$10 at most pharmacies.
Many pharmacy chains include generic meloxicam on their $4 generic drug lists [11]. With a GoodRx coupon, prices may be as low as $3-$6 for 30 tablets.
All insurance plans cover generic meloxicam with minimal or no copay. It is one of the most cost-effective prescription anti-inflammatory medications available [11].
Brand-name Mobic is rarely prescribed or dispensed [1, 8]. Generic versions are universally available and therapeutically equivalent.
For patients who need occasional pain relief (not daily), OTC options like ibuprofen or naproxen may be even less expensive. However, if your doctor has prescribed meloxicam specifically, it may be because of its once-daily dosing, preferential COX-2 selectivity, or your specific medical needs [1, 7].
Is Meloxicam safe during pregnancy or breastfeeding?
Pregnancy: Meloxicam, like all NSAIDs, should be avoided during pregnancy, especially after 20 weeks of gestation [1, 6]. In 2020, the FDA strengthened the warning: avoid NSAIDs at approximately 20 weeks gestation and later due to risks of fetal renal dysfunction leading to oligohydramnios (decreased amniotic fluid) [6]. NSAIDs can also cause premature closure of the ductus arteriosus (a critical fetal blood vessel) and fetal renal impairment in the third trimester [1, 6].
Use during the first trimester has been associated with a possible small increase in miscarriage risk, though data are inconsistent [1]. If anti-inflammatory treatment is needed during pregnancy, consult with your obstetrician about alternatives. Acetaminophen is generally considered safer during pregnancy, though it has limitations.
Breastfeeding: Meloxicam is excreted in breast milk in small amounts [1, 2]. Limited data suggest low infant exposure. Short-term use may be acceptable if clinically needed, but other analgesics (acetaminophen, ibuprofen in short courses) may be preferred due to more extensive safety data during breastfeeding [1, 12].
Is there a generic version of Meloxicam?
Generic meloxicam has been available since 2003 and is manufactured by numerous companies [1, 8]. All generic versions are AB-rated by the FDA as therapeutically equivalent to brand-name Mobic.
There is no clinically meaningful difference between generic meloxicam and Mobic. Both contain the same active ingredient at the same strength with the same effectiveness and safety profile [1, 8].
Brand-name Mobic is essentially never dispensed today. Generic meloxicam costs a fraction of what Mobic originally cost and is universally available [8, 11].
For Caregivers
If you care for someone taking meloxicam long-term [1, 3, 5]:
GI bleeding vigilance: Watch for signs of gastrointestinal bleeding: black or tarry stools, blood in stool, vomiting blood or coffee-ground-like material, and unexplained fatigue or anemia. GI bleeding from NSAIDs can occur without warning [1, 14].
Cardiovascular monitoring: Monitor for cardiovascular symptoms: chest pain, shortness of breath, sudden weakness, slurred speech, or vision changes. NSAIDs carry a boxed warning for cardiovascular thrombotic events [3, 5].
Kidney monitoring: Watch for signs of kidney problems: decreased urination, swelling in the legs/feet/ankles, unexplained weight gain, and fatigue. NSAIDs can impair kidney function, especially in elderly patients or those taking ACE inhibitors/ARBs/diuretics [1, 14].
Ensure adequate hydration, especially in hot weather. Dehydration significantly increases the risk of NSAID-related kidney injury [1].
Remind the person NOT to take other NSAIDs (ibuprofen, naproxen, aspirin for pain) at the same time as meloxicam. OTC pain relievers should be limited to acetaminophen unless the doctor advises otherwise [1, 14].
Frequently asked questions about Meloxicam
References
- [Regulatory] Mobic (meloxicam) tablets and oral suspension prescribing information. Boehringer Ingelheim. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020938s034lbl.pdf Accessed 2025-01-15.
- [Regulatory] Meloxicam. National Library of Medicine DailyMed drug label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55df9bab-dd09-41b9-b8ae-4216ae1e73bf Accessed 2025-01-15.
- [Regulatory] Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302-1308. https://pubmed.ncbi.nlm.nih.gov/16968948/ Accessed 2025-01-15.
- [Regulatory] Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis (PRECISION). N Engl J Med. 2016;375(26):2519-2529. https://pubmed.ncbi.nlm.nih.gov/27040234/ Accessed 2025-01-15.
- [Regulatory] FDA Drug Safety Communication: FDA strengthens warning that NSAIDs increase heart attack and stroke risk. July 2015. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory-drugs Accessed 2025-01-15.
- [Regulatory] FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later. October 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later Accessed 2025-01-15.
- [Regulatory] Dequeker J, Hawkey C, Kahan A, et al. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial. Br J Rheumatol. 1998;37(9):946-951. https://pubmed.ncbi.nlm.nih.gov/10981894/ Accessed 2025-01-15.
- [Regulatory] Drugs@FDA: FDA-Approved Drugs — Mobic NDA 020938. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020938 Accessed 2025-01-15.
- [Regulatory] Turck D, Roth W, Busch U. A review of the clinical pharmacokinetics of meloxicam. Br J Rheumatol. 1996;35 Suppl 1:13-16. https://pubmed.ncbi.nlm.nih.gov/12361269/ Accessed 2025-01-15.
- [Regulatory] Noble S, Balfour JA. Meloxicam. Drugs. 1996;51(3):424-430. https://pubmed.ncbi.nlm.nih.gov/9690947/ Accessed 2025-01-15.
- [Observational] GoodRx. Meloxicam Prices, Coupons & Savings Tips. https://www.goodrx.com/meloxicam Accessed 2025-01-15.
- [Regulatory] UpToDate. Meloxicam: Drug information. Wolters Kluwer. https://www.uptodate.com/contents/meloxicam-drug-information Accessed 2025-01-15.
- [Clinical] Ghlichloo I, Gerriets V. Nonsteroidal Anti-inflammatory Drugs (NSAIDs). StatPearls. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459384/ Accessed 2025-01-15.
- [Regulatory] Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. Circulation. 2008;118(18):1894-1909. https://pubmed.ncbi.nlm.nih.gov/22045842/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: